MILESTONE SCIENTIFIC INC. MLSS Income Statement

Milestone scientific inc. (MLSS)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Product sales, net
1,811	2,300	1,899	2,257	1,915	3,765	1,622	2,428	1,805	2,215	2,853	2,523	3,688	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of products sold
527	761	523	752	618	1,864	1,742	1,021	562	992	1,044	873	1,402	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales, net
-	-	-	-	-	-	-	-	-	-	-	-	-	1,354	3,186	2,371	3,569	2,494	2,459	1,766	2,770	2,670	2,535	2,506	2,620	-	2,444	2,278	-	2,270	2,129	2,326	1,921	1,742	1,745	2,464	2,425	1,926	3,218
Net sales
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,489	-	-	-	-	-	-	-	-	-	-
Cost of products sold
-	-	-	-	-	-	-	-	-	-	-	-	-	499	1,517	789	1,368	750	794	570	933	1,005	829	912	882	964	677	744	812	913	625	854	662	671	597	868	879	725	1,161
Gross profit
1,284	1,539	1,376	1,505	1,297	1,901	-120	1,406	1,242	1,223	1,809	1,650	2,286	854	1,669	1,581	2,201	1,744	1,665	1,196	1,837	1,664	1,705	1,594	1,737	1,834	1,766	1,534	1,677	1,357	1,503	1,472	1,258	1,070	1,148	1,596	1,546	1,201	2,056
Selling, general and administrative expenses
2,785	2,585	2,314	2,517	2,109	1,918	2,886	2,821	3,018	2,934	3,205	3,082	2,707	2,323	2,933	3,290	3,001	2,429	2,480	2,590	1,898	2,655	1,838	1,517	1,392	1,489	1,317	1,340	1,387	1,599	1,391	1,487	1,452	1,323	1,695	1,801	1,624	1,704	1,778
Research and development expenses
107	80	7	95	6	8	1	9	225	30	16	120	105	514	303	309	143	51	20	18	10	13	29	29	15	13	12	42	121	42	60	39	39	47	-7	56	43	60	79
Impairment to long lived assets
-	-	-	-	-	-	1,539	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
2,892	2,665	2,322	2,613	2,115	1,927	4,427	2,831	3,244	2,965	3,222	3,202	2,812	2,838	3,237	3,600	3,144	2,481	2,501	2,609	1,908	2,669	1,867	1,547	1,408	1,502	1,330	1,383	1,509	1,642	1,451	1,526	1,491	1,370	1,688	1,857	1,667	1,765	1,857
Loss from operations
-1,608	-1,126	-946	-1,107	-818	-25	-4,547	-1,424	-2,001	-1,742	-1,413	-1,552	-525	-1,983	-1,568	-2,018	-943	-736	-835	-1,413	-71	-1,004	-162	47	329	331	436	151	167	-285	51	-53	-233	-300	-540	-261	-121	-564	198
Other expenses
-4	-2	-2	-2	-2	-1	-1	-1	-1	-1	-1	-1	-1	-2	-0	-1	-1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-
Interest income
0	0	0	0	1	1	1	1	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of derivative liability
-	-1,788	-1,899	12	40	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	17	-	0	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	2	3	2	0	0	0	0	0	-	-	-	1	-	-	-	-	-	5	30	-	-	-	-	-	-	-	-	-	0	0
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	-	-0	-	-	-	34	33	36	63	42	42	35	34	19	18	17
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total other expenses, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1	1	-	-	-216	-134	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total other expenses, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-196	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss before provision for income taxes and net of equity investments
-1,612	-2,917	-2,848	-1,097	-779	-26	-4,547	-1,424	-2,000	-1,741	-1,411	-1,551	-526	-1,984	-1,569	-2,019	-944	-737	-836	-1,414	-69	-	-358	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Loss) income before provision for income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-169	194	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for income taxes
0	-1	1	14	4	6	1	4	11	0	6	4	7	-99	16	16	46	-	27	13	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss before equity in net earnings (losses) of equity investments
-1,612	-2,916	-2,849	-1,111	-783	-32	-4,549	-1,428	-2,012	-1,741	-1,417	-1,555	-533	-1,885	-1,585	-2,036	-991	-732	-863	-1,428	-69	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest-Amortized debt issuance - cost
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1	1	-	1	1	-	0	0
Interest-Amortization of debt issuance
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Earnings from China Joint Venture
-	32	-19	58	9	71	143	78	36	-	-	15	0	-214	-253	-57	-269	-686	-711	-690	-357	-	-	-	-	-	-212	-47	-	-46	0	-46	-78	-	-60	-	-	-	-
(Loss) Earnings on earnings from equity method investment
-	32	-19	58	9	71	143	78	36	-	-	15	0	-214	-253	-57	-269	-	-711	-690	-357	-	-	-	-	-	-212	-47	-	-46	0	-46	-78	-	-60	-	-	-	-
Net loss
-1,612	-2,883	-2,849	-1,053	-793	38	-4,404	-1,350	-1,975	-1,833	-1,417	-1,540	-577	-2,100	-1,839	-2,094	-1,260	-1,418	-1,574	-2,118	-427	-	-358	-169	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to noncontrolling interests
-12	-20	-12	-11	-10	-139	-11	-6	-101	-41	-6	-61	-73	-192	-137	-507	-510	-12	-5	-45	-8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total other expenses, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	217	77	17	80	36	110	122	-	97	36	-	-	-
Total other expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-20	-	-
Net loss attributable to Milestone Scientific Inc.
-1,600	-2,863	-2,836	-1,041	-782	178	-4,392	-1,343	-1,873	-1,792	-1,410	-1,478	-504	-1,908	-1,701	-1,586	-750	-1,405	-1,569	-2,072	-419	-1,368	-358	-169	194	1,021	218	74	150	-365	15	-164	-355	-405	-637	-298	-141	-583	180
Net loss per share applicable to common stockholders—
Basic (in dollars per share)
-0.03	-0.06	-0.06	-0.02	-0.02	0.01	-0.12	-0.04	-0.06	-0.05	-0.04	-0.05	-0.02	-0.07	-0.06	-0.06	-0.03	-0.22	0.07	-0.09	-0.02	-0.06	-0.02	-0.01	0.01	0.07	0.01	0.00	0.01	-0.02	0.00	-0.01	-0.02	-	-	-	-	-	0.01
Diluted (in dollars per share)
-0.03	-0.06	-0.06	-0.02	-0.02	0.01	-0.12	-0.04	-0.06	-0.05	-0.04	-0.05	-0.02	-0.07	-0.06	-0.06	-0.03	-0.08	-0.07	-0.09	-0.02	-0.06	-0.02	-0.01	0.01	0.06	0.01	0.00	0.01	-0.02	0.00	-0.01	-0.02	-	-	-	-	-	0.01
Weighted average shares outstanding and to be issued—
Basic (in shares)
49,730	49,340	47,721	45,366	40,531	35,545	35,586	35,297	34,766	32,837	33,573	32,399	32,004	30,113	29,155	25,989	22,609	19,976	21,418	22,405	21,919	21,031	21,189	20,246	17,787	18,079	17,333	16,744	16,351	16,762	16,244	15,975	15,338	-	15,121	-	-	-	14,795
Diluted (in shares)
49,730	49,340	47,721	45,366	40,531	35,545	35,586	35,297	34,766	32,837	33,573	32,399	32,004	30,113	29,155	25,989	22,609	17,267	21,418	25,114	21,919	20,549	21,189	20,246	18,268	18,408	17,716	17,056	16,752	16,637	16,369	15,975	15,338	-	15,121	-	-	-	15,172
Net loss applicable to common stockholders
-1,600	-2,863	-2,836	-1,041	-782	178	-4,392	-1,343	-1,873	-1,792	-1,410	-1,478	-504	-	-1,701	-1,586	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-583	180
Loss per share applicable to common stockholders - basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.03	-0.04	-0.02	-0.01	-0.04	-
Weighted average shares outstanding and to be issued - basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15,046	-	-	-
Weighted average shares outstanding and to be issued - Basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14,875	14,862	-
Milestone Education LLC [Member]
Loss from earnings on China joint venture
-	-	-	-	-	-	-1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Loss) Earnings on earnings from equity method investment
-	-	-	-	-	-	-1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
China Joint Venture [Member]
Loss from earnings on China joint venture
-	-	-	-	-	-	-143	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Loss) Earnings on earnings from equity method investment
-	-	-	-	-	-	-143	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-